Elsevier News now has a presence of Twitter. It would be possible to autotweet every single issue of a journal or even every article individually, but it would not be possible to keep up with the feed in a meaningful way. It is doubtful that this would really help any clinician or research in either actively searching for evidence or keeping up to date in their practice. Instead, a more focussed view is taken. There hasn’t yet been much more interest in Twitter from Big Pharma. This may change in the future. Health Business Blog wrote one post a few months ago, and another shortly afterwards following progress. The limitation with microblogging’s focus on Twitter remains that it is a centralised service vulnerable to downtime due to too much traffic or potential cyber attacks. There is not yet any great solution, although Backupify is available to backup tweets and Google has rolled up its improved Twitter search this week.